Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-056870
Filing Date
2008-03-14
Accepted
2008-03-14 12:11:15
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 961293
2 SUPPLY AND DISTRIBUTION AGREEMENT dex1061.htm EX-10.61 174587
3 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 3140
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1590
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 3950
6 CERTIFICATION BY THE CEO dex311.htm EX-31.1 10055
7 CERTIFICATION BY THE CFO dex312.htm EX-31.2 10105
8 CERTIFICATION BY THE CEO PURSUANT TO 18 U.S.C. 1350 dex321.htm EX-32.1 3189
9 CERTIFICATION BY THE CFO PURSUANT TO 18 U.S.C. 1350 dex322.htm EX-32.2 3451
10 GRAPHIC g73121chart.jpg GRAPHIC 43132
  Complete submission text file 0001193125-08-056870.txt   1232405
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23265 | Film No.: 08688375
SIC: 2834 Pharmaceutical Preparations